Published date: 22 December 2020

Closed opportunity - This means that the contract is currently closed. The buying department may be considering suppliers that have already applied, or no suitable offers were made.


Closing: 22 January 2021, 12pm

Contract summary

Industry

  • Medical equipments, pharmaceuticals and personal care products - 33000000

Location of contract

United Kingdom

Value of contract

£550,000

Procurement reference

MEDDISC001-DN517078-38584773

Published date

22 December 2020

Closing date

22 January 2021

Closing time

12pm

Contract start date

9 March 2021

Contract end date

8 March 2024

Contract type

Supply contract

Procedure type

Open procedure

Any interested supplier may submit a tender in response to an opportunity notice.

Contract is suitable for SMEs?

Yes

Contract is suitable for VCSEs?

No


Description

Medicines Discovery Catapult (MDC) are a national facility for collaborative R&D exploring and developing new approaches to the discovery and proof of well targeted medicines, diagnostics and biomarkers. Funded by Innovate UK, an agency of the UK government, MDC are an independent not-for-profit company bringing together a fragmented UK sector of industry, academia, charities, technologists, services, finance companies, SMEs and start-ups who together can turn good science into new, high value products. By sharing problems, rare expertise and assets we support the growth of this new community through a time of radical business and national change.
This Invitation to Tender (ITT) has been issued by MDC for the establishment of a Framework Agreement for the supply and delivery of COVID-19 Samples for delivery to Oncimmune at the following address:

FAO Natalia Hudson,
Oncimmune
MediCity
D6 Thane Road
Nottingham
NG90 6BH

This ITT is in accordance with the Public Contracts Regulations 2015. The Contract Notice has been advertised in the Supplement to the Official Journal of the European Union and on Contracts Finder. The process is being conducted under the EU Procurement Directive's Open Procedure.

Tenders shall remain open for acceptance by MDC for 120 days from the Tender deadline date. The purchase of COVID-19 Samples shall include the cost of collection, storage and delivery as well as any administrative requirements.

The Supplier shall ensure they have measures in place to ensure the fulfilment of the contract in the event of any developments from Britain's exit from the European Union (BREXIT). The Tenderer must state in their Tender Submission if there are any concerns with the Tenderer fulfilling its obligations under the contract due to BREXIT. The costs quoted in the Pricing Schedule appendix 2 are fixed for the life of the Contract and must include the costs to serve associated with the administration and management of the Contract including but not limited to; all costs associated with BREXIT, and all the points in this document, the MDC Contract appendix 1 and the Specification appendix 3.

The Tender is for the establishment of a Framework Agreement for the Supply and Delivery of COVID-19 Samples. It is intended that a maximum of six (6) Suppliers will be appointed to the Framework Agreement. These will be the Tenderers who achieve the highest total scores based on the Award Criteria. If a number of Suppliers score equally and fall into joint sixth (6th) place, then all Tenderers in equal sixth (6th) place will be awarded a place on the Framework Agreement.
Please follow the below link for further information and the tender documents: https://procontract.due-north.com/Advert/
Index?advertId=de2d20a0-a040-eb11-8106-005056b64545


About the buyer

Contact name

Laura Hough

Address

Block 35, Mereside
Alderley Park
Cheshire
SK10 4TG
United Kingdom

Telephone

+44 1625708394

Email

laura.hough@md.catapult.org.uk

Website

https://md.catapult.org.uk/